Historical record - last NADAC effective date: 9/20/2023
Product Information
DOXEPIN HCL 6 MG TABLET is a generic product labeled by Currax Pharmaceuticals LLC, priced at $6.6863 per EA under NDC 44183010630. Its NADAC has been published 180 times since Apr 22, 2020.
FDA first approved this application on Mar 17, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxepin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/1
Manufacturer
Currax Pharmaceuticals LLCNDC
44183010630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/20/2023
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022036FDA Approved
3/17/2010
TE Code
AB
On Market Since
8/1/2010
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 6 MG TABLET has been published 180 times since Apr 22, 2020, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6863 per EA |
|---|---|
| All-time high | $10.5934 (Jun 10, 2020) |
| All-time low | $6.0192 (Aug 23, 2023) |
| Median price | $8.2996 |
| Average price | $8.3689 |
| Largest weekly change | -23.9% (Aug 23, 2023) |
| Weeks tracked | 180 |
| Tracking since | Apr 22, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-24.7%
All
-29.5%
Last surveyed Sep 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Currax Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxepin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 6 MG TABLET, manufactured by Currax Pharmaceuticals LLC, is $6.6863 per EA (NDC 44183010630), effective Sep 27, 2023.
How has the price of DOXEPIN HCL 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 6 MG TABLET has declined 29.5%. It has been tracked across 180 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 6 MG TABLET?
Since Apr 22, 2020, the NADAC for DOXEPIN HCL 6 MG TABLET has ranged from a low of $6.0192 (Aug 23, 2023) to a high of $10.5934 (Jun 10, 2020), with a median of $8.2996 per EA.
Are there cheaper alternatives to DOXEPIN HCL 6 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN HCL 6 MG TABLET, is $1.3716 per EA — about 79% below DOXEPIN HCL 6 MG TABLET.
Who manufactures DOXEPIN HCL 6 MG TABLET?
DOXEPIN HCL 6 MG TABLET (NDC 44183010630) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a generic product.